Ophthalmology · Roanoke, VA
NPI
1932101037
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
707 S Jefferson St
Roanoke, VA, 24016
Phone (540) 344-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$707K
11,309 services
Medicare patients, 2024
1,829
Average age 78
Drug cost, 2024
$738K
12,296 prescriptions
Company payments, 2025
$5,991
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Frank Cotter was code 92083 (vision, hearing, and speech services), 2,610 times for 1,526 patients. In total Frank Cotter billed 11,309 services in 50 codes, and Medicare paid $707K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92083 Vision, Hearing, and Speech Services | Office | 2,610 | 1,526 | $42.97 | $112K |
| 92133 Computerized Ophthalmic Imaging | Office | 2,413 | 1,430 | $22.05 | $53K |
| 99214 Office E&M - Established | Office | 2,294 | 1,162 | $80.11 | $184K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,238 | 912 | $12.33 | $15K |
| 92014 Ophthalmological E&M | Office | 813 | 673 | $76.04 | $62K |
| 99213 Office E&M - Established | Office | 221 | 177 | $69.73 | $15K |
| J7351 Injection, bimatoprost, intracameral implant, 1 microgram | Office | 220 | 14 | $163.04 | $36K |
| 68841 Eye | Facility | 176 | 128 | $12.25 | $2,156 |
| 92020 Ophthalmological E&M | Office | 166 | 166 | $18.63 | $3,092 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 142 | 107 | $177.21 | $25K |
| 92250 Angiography | Office | 135 | 135 | $22.99 | $3,104 |
| 76514 Ultrasound - Nonspecific | Office | 124 | 124 | $7.44 | $923 |
| 92012 Ophthalmological E&M | Office | 101 | 89 | $60.74 | $6,135 |
| 92136 Ultrasound - Nonspecific | Office | 99 | 95 | $30.26 | $2,996 |
| 66183 Fluid Flow and Drainage of Eye (Any Method) | Facility | 75 | 65 | $768.35 | $58K |
By year: 2022 $754K for 10,011 services; 2023 $696K for 9,922 services; 2024 $707K for 11,309 services.
Medicare prescription drug claims, 2024
In 2024, the drug Frank Cotter prescribed most often to Medicare patients was Latanoprost, with 4,062 prescriptions and refills. In total Frank Cotter wrote 12,296 Medicare prescriptions that cost $738K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 4,062 | 7,948 | 949 | $28K |
| Dorzolamide Hcl Generic | 1,867 | 3,338 | 452 | $30K |
| Brimonidine Tartrate Generic | 954 | 1,799 | 252 | $10K |
| Prednisolone Acetate Generic | 943 | 1,075 | 385 | $27K |
| Timolol Maleate Generic | 926 | 2,261 | 301 | $7,184 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 923 | 2,191 | 272 | $15K |
| Lumigan Bimatoprost | 449 | 785 | 116 | $198K |
| Ciprofloxacin Hcl Generic | 358 | 362 | 245 | $3,839 |
| Simbrinza Brinzolamide/Brimonidine Tart | 348 | 581 | 93 | $97K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 203 | 332 | 50 | $21K |
| Travoprost Generic | 163 | 278 | 37 | $25K |
| Vyzulta Latanoprostene Bunod | 145 | 204 | 36 | $59K |
| Ketorolac Tromethamine Generic | 128 | 181 | 89 | $2,332 |
| Combigan Brimonidine Tartrate/Timolol | 91 | 147 | 25 | $23K |
| Brinzolamide Generic | 84 | 129 | 23 | $19K |
Brand drugs: 3,040 claims; generic drugs: 9,256 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Frank Cotter $5,991 ($5,991 in general payments such as food, travel and fees) from 4 companies. The largest payer was Glaukos Corporation with $4,844.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.